Roflumilast Cream 0.15% in Patients With Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials. J of Skin 2024, 8 (2), s372. https://doi.org/10.25251/skin.8.supp.372.